Document is current
Any future updates will be listed below
-
Authors
Yin, Xuan
Geng, Renhao
Chen, Junjun
Xu, Bin
Ma, Hui
Liu, Yingting
Zheng, Xiao
Chen, Lujun
-
Funding
Funding for this research was provided by:
Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX23_3265)
the Major Program of Science and Technology Project of Changzhou Health Commission (ZD202329)
the National Natural Science Foundation of China (82172689)
the Provincial-level Talent Program for National Center of Technology Innovation for Biopharmaceuticals (NCTIB2024JS0101)
the Key R&D Project of Jiangsu Province (BE2022721)
the Leading Talent of Changzhou “The 14th Five-Year Plan” High-Level Health Talents Training Project (2024CZLJ009)
Changzhou Medical Center of Nanjing Medical University (CZKYCMCC202301)
Prospective Research Program of Changzhou Xitaihu Development Foundation For Frontier Cell-Therapeutic Technology (2024-P-027)
Changzhou Science and Technology Support Program (CE20235057)
- License Information
-
More Information
Article History
Received: 19 January 2025
Accepted: 18 July 2025
First Online: 7 August 2025
Change Date: 9 August 2025
Change Type: Update
Change Details: The original article has been updated: Authors Xuan Yin and Renhao Geng are captured as equal contributors.
Declarations
:
: The present study involving in human participants was approved by the Clinical Research Ethics Committee at Outdo Biotech (Shanghai, China, SHYJS-CP-1704002). The studies adhered to local laws and institutional guidelines.
: Not applicable.
: This study was approved by the Ethics Committee of Taizhou Hospital of Zhejiang Province. The approval was granted with a waiver of informed consent (Approval No. K20200506).
: The authors declare no competing interests.
